Creating a mobile app to help adolescents manage asthma
Official title: IMAAP: Development and evaluation of an Interactive Mobile Asthma Action Plan
Funded at Cincinnati Childrens Hosp Med Ctr · NIH-10984558 · Data updated 2026-11-12
This study is testing a new app that helps teenagers with asthma manage their condition better by giving them personalized advice based on their symptoms and lung function, while also making sure that young people from underserved communities have a say in how the app is created.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project start | July 17, 2024 |
| Project end | May 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $441,375 |
| NIH project number | 1R21NR020894-01A1 |
| Project ID | NIH-10984558 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adolescents with asthma, particularly those from historically marginalized populations facing challenges in accessing healthcare.
✕Less likely to help
Patients who do not have asthma or those who are not adolescents may not receive any benefit from this research.
What this research studies
This research focuses on developing and evaluating an Interactive Mobile Asthma Action Plan (IMAAP) designed to assist adolescents in managing their asthma effectively. The app will provide personalized treatment recommendations based on real-time assessments of lung function and symptoms, making it easier for young patients to adhere to their prescribed asthma management plans. By involving adolescents from marginalized communities in the development process, the project aims to address barriers to care and improve health equity. The app will also support caregivers and healthcare providers in delivering better asthma care.
Why it matters
Potential benefit: If successful, this research could empower adolescents with asthma to manage their condition more effectively, potentially reducing the frequency of asthma attacks and improving overall health outcomes.
How similar studies have gone: Previous research has shown success in using mobile health technologies to improve chronic disease management, indicating that this approach has potential for positive outcomes.
Where this research is happening
-
Cincinnati Childrens Hosp Med Ctr
Cincinnati, United States Active
Researchers
- Principal investigator: Ramsey, Rachelle R. — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Ramsey, Rachelle R.
Related research
Other NIH-funded projects on the same topics.
-
GLP-1 receptor agonists as immune targets to treat asthma in lean and obese adults
Aims to understand how GLP-1R‑agonist diabetes medicines may directly calm immune cells to reduce asthma in adults who are lean or obese.
-
Understanding how a type of immune cell called ILC2s affect asthma in adults
This grant studies how group 2 innate lymphoid cells influence asthma in adults to help identify new ways to manage airway inflammation.
-
Expanding understanding of asthma in kids through airways and blood profiling
A study at UC San Francisco will profile blood and nasal/sputum samples from 300 youth (including 200 with asthma) over a year to understand how environmental and social factors influence asthma in marginalized communities.
-
Preventing and improving asthma care for children in urban communities
This program will try several approaches — from giving helpful bacteria to babies to allergy immunotherapy and advanced airway testing — to prevent and better treat asthma in children who live in cities.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.